These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 26416305)
41. Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period. van de Luijtgaarden MW; Jager KJ; Segelmark M; Pascual J; Collart F; Hemke AC; Remón C; Metcalfe W; Miguel A; Kramar R; Aasarød K; Abu Hanna A; Krediet RT; Schön S; Ravani P; Caskey FJ; Couchoud C; Palsson R; Wanner C; Finne P; Noordzij M Nephrol Dial Transplant; 2016 Jan; 31(1):120-8. PubMed ID: 26311215 [TBL] [Abstract][Full Text] [Related]
42. Symptom perception and self-care practice for uraemic pruritus in patients receiving haemodialysis. Huang CY; Chen CJ; Lin JN; Shih YY; Chen CF J Ren Care; 2024 Mar; 50(1):36-46. PubMed ID: 36451513 [TBL] [Abstract][Full Text] [Related]
43. Assessment of pruritus characteristics and impact on burn survivors. Parnell LK; Nedelec B; Rachelska G; LaSalle L J Burn Care Res; 2012; 33(3):407-18. PubMed ID: 22210065 [TBL] [Abstract][Full Text] [Related]
44. Parametres of clinical and biohumoral status of pruritus in patients on chronic haemodialysis. Stolić R; Trajković G; Perić V; Jovanović A; Lazarević T; Subarić-Gorgieva G Med Pregl; 2007; 60 Suppl 2():101-3. PubMed ID: 18928171 [TBL] [Abstract][Full Text] [Related]
45. Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial. Gunal AI; Ozalp G; Yoldas TK; Gunal SY; Kirciman E; Celiker H Nephrol Dial Transplant; 2004 Dec; 19(12):3137-9. PubMed ID: 15575002 [TBL] [Abstract][Full Text] [Related]
46. Uraemic pruritus: relief of itching by gabapentin and pregabalin. Rayner H; Baharani J; Smith S; Suresh V; Dasgupta I Nephron Clin Pract; 2012; 122(3-4):75-9. PubMed ID: 23548570 [TBL] [Abstract][Full Text] [Related]
47. Baby oil therapy for uremic pruritus in haemodialysis patients. Lin TC; Lai YH; Guo SE; Liu CF; Tsai JC; Guo HR; Hsu HT J Clin Nurs; 2012 Jan; 21(1-2):139-48. PubMed ID: 22093006 [TBL] [Abstract][Full Text] [Related]
48. Measuring the prevalence of chronic itch in the general population: development and validation of a questionnaire for use in large-scale studies. Matterne U; Strassner T; Apfelbacher CJ; Diepgen TL; Weisshaar E Acta Derm Venereol; 2009; 89(3):250-6. PubMed ID: 19479120 [TBL] [Abstract][Full Text] [Related]
49. Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients. Balaskas EV; Bamihas GI; Karamouzis M; Voyiatzis G; Tourkantonis A Nephron; 1998; 78(4):395-402. PubMed ID: 9578065 [TBL] [Abstract][Full Text] [Related]
50. Are itch and chronic pain associated in adults? Results of a large population survey in Norway. Dalgard F; Dawn AG; Yosipovitch G Dermatology; 2007; 214(4):305-9. PubMed ID: 17460401 [TBL] [Abstract][Full Text] [Related]
51. The Influence of Renal Centre and Patient Sociodemographic Factors on Home Haemodialysis Prevalence in the UK. Jayanti A; Foden P; Rae A; Morris J; Brenchley P; Mitra S Nephron; 2017; 136(2):62-74. PubMed ID: 28178704 [TBL] [Abstract][Full Text] [Related]
52. Comparison of pregabalin with doxepin in the management of uremic pruritus: a randomized single blind clinical trial. Foroutan N; Etminan A; Nikvarz N; Shojai Shahrokh Abadi M Hemodial Int; 2017 Jan; 21(1):63-71. PubMed ID: 27397522 [TBL] [Abstract][Full Text] [Related]
53. Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Narita I; Alchi B; Omori K; Sato F; Ajiro J; Saga D; Kondo D; Skatsume M; Maruyama S; Kazama JJ; Akazawa K; Gejyo F Kidney Int; 2006 May; 69(9):1626-32. PubMed ID: 16672924 [TBL] [Abstract][Full Text] [Related]
54. Home haemodialysis-international trends and variation. MacGregor MS; Agar JW; Blagg CR Nephrol Dial Transplant; 2006 Jul; 21(7):1934-45. PubMed ID: 16537659 [TBL] [Abstract][Full Text] [Related]
55. Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: a prospective, crossover study. Solak Y; Biyik Z; Atalay H; Gaipov A; Guney F; Turk S; Covic A; Goldsmith D; Kanbay M Nephrology (Carlton); 2012 Nov; 17(8):710-7. PubMed ID: 22909343 [TBL] [Abstract][Full Text] [Related]
56. Prevalence and Outcomes of Chronic Kidney Disease Associated Pruritus: International Results from PDOPPS. Tennankore KK; McCullough KP; Bieber B; Cho Y; Johnson DW; Kanjanabuch T; Kawanishi H; Kim YL; Lambie M; Rigatto C; Shen J; Schreiber M; Perl J; Pisoni RL Clin J Am Soc Nephrol; 2024 Oct; ():. PubMed ID: 39392697 [TBL] [Abstract][Full Text] [Related]
57. Gabapentin: a promising drug for the treatment of uremic pruritus. Naini AE; Harandi AA; Khanbabapour S; Shahidi S; Seirafiyan S; Mohseni M Saudi J Kidney Dis Transpl; 2007 Sep; 18(3):378-81. PubMed ID: 17679749 [TBL] [Abstract][Full Text] [Related]
58. Assessing Pruritus in Hidradenitis Suppurativa: A Cross-Sectional Study. Vossen ARJV; Schoenmakers A; van Straalen KR; Prens EP; van der Zee HH Am J Clin Dermatol; 2017 Oct; 18(5):687-695. PubMed ID: 28429245 [TBL] [Abstract][Full Text] [Related]
59. [Current peritoneal dialysis compared with haemodialysis: medium-term survival analysis of incident dialysis patients in the Canary Islands in recent years]. Rufino JM; García C; Vega N; Macía M; Hernández D; Rodríguez A; Maceira B; Lorenzo V Nefrologia; 2011; 31(2):174-84. PubMed ID: 21461011 [TBL] [Abstract][Full Text] [Related]
60. Epidemiology and burden of chronic kidney disease-associated pruritus. Kim D; Pollock C Clin Kidney J; 2021 Dec; 14(Suppl 3):i1-i7. PubMed ID: 34987777 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]